Clinical Trial Update: HORIZON-PFT: Pivotal Fracture Trial [Phase 3]

View source ↗

Summary

Novartis reports the completion of the pivotal Phase 3 HORIZON-PFT fracture trial in osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED